Nalmefene Implant Safety Study in Healthy Adults
Part of Mental health clinical trials.
This trial tests a new implant form of the medicine nalmefene to see if it is safe and well-tolerated in healthy adults. It is an early-phase study that helps researchers understand how the body reacts to the implant before testing it in people with opioid use problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old, a non-smoker, and have a healthy weight (BMI between 18.5 and 35).
- You are generally healthy with no major medical conditions (like heart disease, depression, or skin problems) and no recent surgeries.
- You have not used any recreational drugs, alcohol abuse, or certain medications (including over-the-counter ones) in the past month or longer.
- You are willing to use effective birth control if you or your partner could become pregnant, and you are not pregnant or breastfeeding.
- You do not have allergies to the study drug (nalmefene) or to local anesthetics like lidocaine.
- You have no tattoos, scars, or skin conditions on your inner upper arms that could affect the implant placement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether nalmefene, a non-opioid medicine, can reduce craving episodes in people with behavioral addictions like gambling, food addiction, or sexual addiction. Participants keep tracking cravings weekly, and compare the nalmefene effect against a placebo in addition to their usual care.
This trial compares two forms of naltrexone (a medication used for alcohol and opioid dependence) in healthy volunteers. It tests how well the body processes and tolerates a low or high-dose implant versus the standard monthly injection.
This study tests a new implant (BICX104) with or without bupropion to see how safe it is and how it works in the body, compared to an existing treatment (Vivitrol). If you are healthy and not using opioids, you may be eligible to help researchers understand if this implant could be a new option for treatment.
This Phase 2 study tests whether a long-acting naltrexone implant can help people with opioid use disorder stay away from opioid relapse. You may get the implant after safely finishing opioid withdrawal and stopping other naltrexone dosing at the right time.
This trial tests how a new combination of oxycodone and nafamostat works in the body. It is for healthy volunteers aged 18 to 55 to help understand the drug's safety and how it is processed.
This trial tests an oral medication called MG001 in healthy adults who have used oral opioids recently, to see how safe it is. It may help researchers understand if this new treatment could one day help with opioid-related conditions.
Hear when a new Opioid Abuse and Addiction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.